Company & Sponsor Intelligence

Weill Medical College of Cornell University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting3

Completed5

Countries1

Therapeutic footprint

alzheimersdepressionepilepsypain_neuropathyparkinsons

Indexed studies

NCT00195052Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients
epilepsy · United StatesTERMINATED

NCT05218967Virtual Reality in Laryngology
pain_neuropathy · United StatesNA

NCT03038867Impact of Duloxetine on Male Fertility
depression · United StatesPHASE2

NCT04289298Reaching and Engaging Depressed Senior Center Clients
depression · United StatesNA

NCT06975059Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
parkinsons · United StatesNA

NCT05447689Mind-Body Skills Group for Graduate Students
depression · United StatesNA

NCT00601055Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
depression · United StatesNA

NCT03649724The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
alzheimers · United StatesPHASE2

NCT02292849Peer to Peer Delivery of Behavioral Activation
depression · United StatesNA

NCT05183230WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
depression · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →